Smartphone Technology to Alleviate Malignant Pain (STAMP) + Cognitive Behavioral Therapy for Pain (STAMP+CBT) The purpose of the study is to develop and refine the mHealth pain-CBT app intervention and carry out a randomized pilot to test the novel mHealth (Mobile health technology) intervention, which harmonizes psychological and pharmacological support for advanced cancer pain.
The name of the study smartphone application involved in this study is:
-STAMP+CBT
Age ≥ 22 years
Patient diagnosed with an active cancer diagnosis (locally advanced solid tumor malignancy, multiple myeloma, or other advanced hematologic malignancy), either undergoing active treatment or receiving treatment for an advanced cancer or are receiving supportive/palliative care
Chronic pain related to cancer or treatment (> pain score of 4 on a 0-10 scale)
Has an active prescription for at least one opioid medication to treat their cancer pain (i.e. not for post-surgical pain)
Patients in survivorship: patients who have completed their treatment regimens, are not actively receiving treatment for an advanced cancer, or have a cancer that is in remission
Cognitive impairment that would interfere with study participation, as judged by treating clinician (e.g. delirium, dementia)
Inability to speak English (the intervention has not yet been translated to Spanish)
Currently in CBT treatment
Dana-Farber Cancer Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator